Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to SARS-CoV-2 Infection
Related studies linked through entity extraction aliases.
Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity
- Status
- COMPLETED
- Phase
- PHASE3
Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19
- Status
- COMPLETED
- Phase
- N/A
COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells
- Status
- UNKNOWN
- Phase
- NA
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial
- Status
- COMPLETED
- Phase
- PHASE2
COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)
- Status
- COMPLETED
- Phase
- N/A
Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
- Status
- UNKNOWN
- Phase
- PHASE2
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
- Status
- COMPLETED
- Phase
- PHASE1
PET/CT Imaging in COVID-19 Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Asymptomatic COVID-19 Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19)
- Status
- UNKNOWN
- Phase
- N/A
Plasma Therapy of COVID-19 in Severely Ill Patients
- Status
- COMPLETED
- Phase
- PHASE2
COVID19-hematological Malignancies: the Italian Hematology Alliance
- Status
- UNKNOWN
- Phase
- N/A
Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection
- Status
- TERMINATED
- Phase
- PHASE2
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
- Status
- COMPLETED
- Phase
- PHASE3
Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Characteristics and Outcomes of Pediatric COVID-19
- Status
- COMPLETED
- Phase
- N/A